Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (viii)
From GxPlex
| Document information | |
|---|---|
| Reference | USA 21 CFR Part 312 09-Apr-2025 |
| Validity area | USA |
| Scope(s) | HM |
| Document name | 21 CFR Part 312 |
| Version / Revision | 09-Apr-2025 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | Title 21 —Food and Drugs
Chapter I —Food and Drug Administration, Department of Health and Human Services Subchapter D—Drugs for Human Use Part 312 Investigational New Drug Application https://www.ecfr.gov/current/title-21 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 2 — Unit 2.3.2 |
| Scope | HM |
| Document part | § 312.53
(viii) |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Sub-investigator, Investigational drug (IMP), Requirements, FDA |
Content
§ 312.53 Selecting investigators and monitors. […] (viii) A list of the names of the subinvestigators (e.g., research fellows, residents) who will be assisting the investigator in the conduct of the investigation(s). […]
